Project Grant HT94252510976
Award Date 11/1/25
Completion Date 10/31/29
Dollars Obligated $2.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
- This $2,469,162 federal Project Grant was awarded on September 30, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Wake Forest University Health Sciences (WFUHS). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the use of allografts versus autografts to improve timely return to duty...
- This federal Project Grant award of $1,480,812.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Wake Forest University Health Sciences (WFUHS). The funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The research project, titled "INTRAOSSEOUS ANTIBIOTICS FOR OSSEOINTEGRATION (IOAOI)", will be conducted at WFUHS in Winston-Salem,...
- The Department of Defense's Defense Health Agency awarded Wake Forest University Health Sciences (WFUHS) a $1,799,493 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on October 1, 2025, will fund research to develop PEDF-enriched exosomes for improving urethral sphincter function after radical prostatectomy. This advanced biomedical research initiative aims to transform healthcare for military service members and the broader public by...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,477,108 to Wake Forest University Health Sciences to conduct research on single-implant versus dual-implant fixation of distal femur extra-articular and complete articular fractures. The project will run from September 30, 2023 through September 29, 2027. Wake Forest University Health Sciences, an academic medical center, will lead this research...
- The Defense Health Agency awarded Wake Forest University Health Sciences a $810,171 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Therapeutic Effects of Peroxisome Proliferator-Activated Receptor Alpha Agonist on Combat-Induced Proliferative Vitreoretinopathy." The grant runs from September 1, 2025 through August 31, 2028 and supports advanced biomedical research aimed at developing innovative medical solutions to...
- This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
- This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
- Wake Forest University Health Sciences was awarded a $2,486,254 project grant from the Defense Health Agency to conduct a randomized clinical trial evaluating primary subtalar arthrodesis for calcaneal fractures. The grant is funded through the Military Medical Research and Development program, which supports biomedical research to improve health care for service members and the public through innovative solutions for battlefield medicine. Over a four-year period ending September 2027, Wake...
- This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
- This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...